Skip to Content
MilliporeSigma
  • Developing structure-activity relationships for the prediction of hepatotoxicity.

Developing structure-activity relationships for the prediction of hepatotoxicity.

Chemical research in toxicology (2010-06-18)
Nigel Greene, Lilia Fisk, Russell T Naven, Reine R Note, Mukesh L Patel, Dennis J Pelletier
ABSTRACT

Drug-induced liver injury is a major issue of concern and has led to the withdrawal of a significant number of marketed drugs. An understanding of structure-activity relationships (SARs) of chemicals can make a significant contribution to the identification of potential toxic effects early in the drug development process and aid in avoiding such problems. This process can be supported by the use of existing toxicity data and mechanistic understanding of the biological processes for related compounds. In the published literature, this information is often spread across diverse sources and can be varied and unstructured in quality and content. The current work has explored whether it is feasible to collect and use such data for the development of new SARs for the hepatotoxicity endpoint and expand upon the limited information currently available in this area. Reviews of hepatotoxicity data were used to build a structure-searchable database, which was analyzed to identify chemical classes associated with an adverse effect on the liver. Searches of the published literature were then undertaken to identify additional supporting evidence, and the resulting information was incorporated into the database. This collated information was evaluated and used to determine the scope of the SARs for each class identified. Data for over 1266 chemicals were collected, and SARs for 38 classes were developed. The SARs have been implemented as structural alerts using Derek for Windows (DfW), a knowledge-based expert system, to allow clearly supported and transparent predictions. An evaluation exercise performed using a customized DfW version 10 knowledge base demonstrated an overall concordance of 56% and specificity and sensitivity values of 73% and 46%, respectively. The approach taken demonstrates that SARs for complex endpoints can be derived from the published data for use in the in silico toxicity assessment of new compounds.

MATERIALS
Product Number
Brand
Product Description

Supelco
L-Ascorbic acid, analytical standard
Pricing and availability is not currently available.
Supelco
Chloroform solution, certified reference material, 5000 μg/mL in methanol
Pricing and availability is not currently available.
Supelco
Nicotinic acid, analytical standard
Pricing and availability is not currently available.
SAFC
Sodium chloride solution, 5 M
Pricing and availability is not currently available.
Supelco
Cyclosporin A, VETRANAL®, analytical standard
Pricing and availability is not currently available.
Supelco
2-Ethylhexyl 4-methoxycinnamate, analytical standard
Pricing and availability is not currently available.
Sigma-Aldrich
Vitamin D2 solution, 100 μg/mL in ethanol, 98% (CP)
Pricing and availability is not currently available.
Sigma-Aldrich
L-Ascorbic acid, FCC, FG
Pricing and availability is not currently available.
Sigma-Aldrich
Sodium chloride physiological solution, BioUltra, tablet
Pricing and availability is not currently available.
Sigma-Aldrich
Erythromycin, meets USP testing specifications
Pricing and availability is not currently available.
Sigma-Aldrich
Tromethamine, meets USP testing specifications
Pricing and availability is not currently available.
Sigma-Aldrich
Doxorubicin hydrochloride, suitable for fluorescence, 98.0-102.0% (HPLC)
Pricing and availability is not currently available.
Sigma-Aldrich
Rifampicin, ≥95% (HPLC), powder or crystals
Pricing and availability is not currently available.
Sigma-Aldrich
Cephalothin sodium salt
Pricing and availability is not currently available.
Sigma-Aldrich
5-Iodo-2′-deoxyuridine, ≥99% (HPLC)
Pricing and availability is not currently available.
Sigma-Aldrich
Adenine 9-β-D-arabinofuranoside, ≥99%
Pricing and availability is not currently available.
Sigma-Aldrich
19-Norethindrone, ≥98%, powder
Pricing and availability is not currently available.
Sigma-Aldrich
Promethazine hydrochloride
Pricing and availability is not currently available.
Sigma-Aldrich
Sodium chloride, tablet
Pricing and availability is not currently available.
Sigma-Aldrich
Capsaicin, ≥95%, from Capsicum sp.
Pricing and availability is not currently available.
Sigma-Aldrich
Phenyl isothiocyanate, Sigma Grade, 8.36 M, suitable for solid phase protein sequencing analysis, ≥99% (GC), liquid
Pricing and availability is not currently available.
Sigma-Aldrich
Clonidine hydrochloride, solid
Pricing and availability is not currently available.
Sigma-Aldrich
Vinblastine sulfate salt, ≥97% (HPLC)
Pricing and availability is not currently available.
Sigma-Aldrich
Trimethoprim, ≥98.5%
Pricing and availability is not currently available.
Sigma-Aldrich
Pindolol, ≥98% (TLC), powder
Pricing and availability is not currently available.
Sigma-Aldrich
Retinyl palmitate, potency: ≥1,700,000 USP units per g
Pricing and availability is not currently available.
Supelco
Warfarin, analytical standard
Pricing and availability is not currently available.
Sigma-Aldrich
Gallamine triethiodide, ≥98% (TLC), powder, muscarinic receptor antagonist
Pricing and availability is not currently available.
Sigma-Aldrich
Rifampicin, suitable for plant cell culture, BioReagent, ≥95% (HPLC), powder or crystals
Pricing and availability is not currently available.
Sigma-Aldrich
Fluorouracil, meets USP testing specifications
Pricing and availability is not currently available.